Clinical trial
An Open-label Pilot Study to Evaluate Medication Satisfaction With Apixaban Versus Enoxaparin for Thrombosis Prevention After Head and Neck Cancer Surgery
NCT07189897 is registered in ClinicalTrials.gov with Kiranya Arnold as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Pilot Study to Evaluate Medication Satisfaction With Apixaban Versus Enoxaparin for Thrombosis Prevention After Head and Neck Cancer Surgery
- Lead sponsor
- Kiranya Arnold
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 31, 2025
- Completion date
- December 31, 2027
- Enrollment
- 76 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer, venous thromboembolism